Effect of sildenafil citrate on interleukin-1β-induced nitric oxide synthesis and iNOS expression in SW982 cells

被引:25
作者
Kim, Kyung-Ok [2 ]
Park, Shin-Young [1 ]
Han, Chang-Woo [3 ]
Chung, Hyun Kee [3 ]
Ryu, Dae-Hyun [4 ]
Han, Joong-Soo [1 ]
机构
[1] Hanyang Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 133791, South Korea
[2] Univ Rochester, Med Ctr, Dept Orthopaed, Ctr Musculoskeletal Res, Rochester, NY 14642 USA
[3] Hanyang Univ, Dept Orthoped Surg, Coll Med, Seoul 133791, South Korea
[4] Hanyang Univ, Dept Rheumatol, Coll Med, Seoul 133791, South Korea
关键词
cyclic nucleotide phosphodiesterases; type; 5; interleukin-1; beta; nitric oxide; nitric oxide synthase type II; sildenafil;
D O I
10.3858/emm.2008.40.3.286
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to identify the effect of sildenafil citrate on IL-1 beta-induced nitric oxide (NO) synthesis and iNOS expression in human synovial sarcoma SW982 cells. IL-1 beta stimulated the cells to generate NO in both dose- and time-dependent manners. The IL-1 beta-induced NO synthesis was inhibited by guanylate cyclase (GC) inhibitor, LY83583. When the cells were treated with 8-bromo-cGMP, a hydrolyzable analog of cGMP, NO synthesis was increased upto 5-fold without IL-1 beta treatment suggesting that cGMP is an essential component for increasing the NO synthesis. Synoviocytes and chondrocytes contain strong cGMP phosphodiesterase (PDE) activity, which has biochemical features of PDE5. When SW982 cells were pretreated with sildenafil citrate (Viagra), a PDE5 specific inhibitor, sildenafil citrate significantly inhibited IL-1 beta-induced NO synthesis and iNOS expressions. From this result, we noticed that PDE5 activity is required for IL-1 beta-induced NO synthesis and iNOS expressions in human synovial sarcoma cells, and sildenafil citrate may be able to suppress an inflammatory reaction of synovium through inhibition of NO synthesis and iNOS expression by cytokines.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 30 条
[1]   INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160
[2]   NITRIC-OXIDE - A PHYSIOLOGICAL MESSENGER MOLECULE [J].
BREDT, DS ;
SNYDER, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :175-195
[3]   Cyclic GMP phosphodiesterase-5: Target of sildenafil [J].
Corbin, JD ;
Francis, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) :13729-13732
[4]   Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney [J].
Dousa, TP .
KIDNEY INTERNATIONAL, 1999, 55 (01) :29-62
[5]  
FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347
[6]   Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes [J].
Geng, Y ;
Zhou, L ;
Thompson, WJ ;
Lotz, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) :27484-27491
[7]  
Grabowski PS, 1997, BRIT J RHEUMATOL, V36, P651
[8]   Elevated nitric oxide production in rheumatoid arthritis - Detection using the fasting urinary nitrate:creatinine ratio [J].
Grabowski, PS ;
England, AJ ;
Dykhuizen, R ;
Copland, M ;
Benjamin, N ;
Reid, DM ;
Ralston, SH .
ARTHRITIS AND RHEUMATISM, 1996, 39 (04) :643-647
[9]  
HALL IP, 1993, BRIT J CLIN PHARMACO, V35, P1